Oliver Fiehn Selected Research

Lys(8)- oxytocin (OXL)

2/2022	Plasma Oxylipin Profile Discriminates Ethnicities in Subjects with Non-Alcoholic Steatohepatitis: An Exploratory Analysis.
1/2020	Impact of a weight loss and fitness intervention on exercise-associated plasma oxylipin patterns in obese, insulin-resistant, sedentary women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oliver Fiehn Research Topics

Disease

39	Neoplasms (Cancer) 03/2022 - 09/2008
15	Inflammation (Inflammations) 07/2022 - 06/2011
15	Insulin Resistance 06/2021 - 03/2010
12	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 01/2012
9	Obesity 07/2022 - 02/2015
9	Breast Neoplasms (Breast Cancer) 10/2019 - 05/2011
7	Adenocarcinoma 01/2022 - 05/2015
7	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2015
5	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2015
5	Liver Diseases (Liver Disease) 12/2020 - 07/2012
5	Weight Loss (Weight Reduction) 01/2020 - 01/2014
4	Non-alcoholic Fatty Liver Disease 05/2022 - 01/2017
4	Hypoxia (Hypoxemia) 01/2021 - 01/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 06/2013
3	Asthma (Bronchial Asthma) 06/2021 - 05/2015
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2020
3	Triple Negative Breast Neoplasms 01/2021 - 01/2016
3	Fatty Liver 01/2021 - 10/2017
3	Starvation 01/2020 - 12/2005
3	Carcinoma (Carcinomatosis) 04/2019 - 09/2008
3	Adenocarcinoma of Lung 01/2017 - 11/2015
3	Body Weight (Weight, Body) 01/2017 - 01/2014
3	Infections 12/2016 - 05/2012
2	Pain (Aches) 01/2022 - 01/2020
2	Major Depressive Disorder (Major Depressive Disorders) 10/2021 - 01/2013
2	Ulcerative Colitis 01/2021 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 02/2020
2	Cognitive Dysfunction 01/2020 - 12/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
2	Thrombosis (Thrombus) 01/2020 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2019 - 01/2017

Drug/Important Bio-Agent (IBA)

34	LipidsIBA 07/2022 - 09/2008
20	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2010
16	Proteins (Proteins, Gene)FDA Link 11/2020 - 03/2007
14	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 04/2011
12	Amino Acids FDA Link 01/2022 - 09/2008
9	Fatty Acids (Saturated Fatty Acids)IBA 05/2022 - 03/2010
8	Insulin (Novolin)FDA Link 06/2021 - 05/2011
8	Pharmaceutical PreparationsIBA 11/2020 - 01/2013
8	EnzymesIBA 12/2019 - 02/2012
7	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022 - 05/2011
6	OxylipinsIBA 02/2022 - 10/2017
6	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2022 - 06/2015
6	Triglycerides (Triacylglycerol)IBA 01/2022 - 02/2012
5	Biological ProductsIBA 01/2022 - 01/2017
5	Estrogen ReceptorsIBA 01/2021 - 05/2011
5	Glutamic Acid (Glutamate)FDA Link 01/2018 - 12/2013
4	Methionine (L-Methionine)FDA Link 01/2022 - 06/2015
4	SphingomyelinsIBA 01/2020 - 12/2014
4	CeramidesIBA 01/2020 - 12/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019 - 01/2012
4	CarbonIBA 08/2019 - 10/2012
4	Branched-Chain Amino AcidsIBA 04/2017 - 07/2014
3	AntioxidantsIBA 05/2022 - 05/2015
3	PolyaminesIBA 03/2022 - 01/2017
3	EndocannabinoidsIBA 02/2022 - 01/2020
3	Cholesterol Esters (Cholesteryl Esters)IBA 01/2022 - 01/2017
3	Epoxide HydrolasesIBA 01/2022 - 10/2008
3	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2022 - 06/2015
3	CytokinesIBA 06/2021 - 05/2015
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2021 - 01/2017
3	Arginine (L-Arginine)FDA Link 06/2021 - 05/2015
3	AutoantibodiesIBA 01/2021 - 06/2012
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 06/2011
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021 - 07/2012
3	Interleukin-8 (Interleukin 8)IBA 01/2021 - 06/2011
3	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2021 - 10/2017
3	Choline (Choline Chloride)IBA 01/2021 - 01/2018
3	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 08/2016
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020 - 05/2011
3	CholesterolIBA 10/2019 - 01/2016
3	MicroRNAs (MicroRNA)IBA 10/2019 - 10/2017
3	trimethyloxamine (trimethylamine N-oxide)IBA 01/2018 - 07/2015
3	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2017 - 01/2014
3	Glutamine (L-Glutamine)FDA Link 08/2016 - 12/2013
2	Lys(8)- oxytocin (OXL)IBA 02/2022 - 01/2020
2	Serine (L-Serine)FDA Link 01/2022 - 08/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 11/2020
2	HydrolasesIBA 01/2022 - 05/2015
2	Messenger RNA (mRNA)IBA 01/2022 - 03/2007
2	AcidsIBA 01/2021 - 04/2014
2	Hallucinogens (Psychedelics)IBA 01/2021 - 01/2019
2	prostaglandin E3 (PGE3)IBA 01/2021 - 01/2021
2	HomocysteineIBA 01/2021 - 01/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 01/2017
2	Docosahexaenoic AcidsIBA 01/2021 - 01/2021
2	Eicosapentaenoic AcidIBA 01/2021 - 01/2021
2	CalciumIBA 01/2021 - 10/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2016
2	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 01/2020
2	Arachidonic Acid (Vitamin F)IBA 01/2021 - 06/2015
2	Linoleic Acid (Linoleate)IBA 01/2020 - 10/2017
2	EicosanoidsIBA 01/2020 - 06/2015
2	Phenylalanine (L-Phenylalanine)FDA Link 01/2020 - 04/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2014
2	Metformin (Glucophage)FDA LinkGeneric 12/2019 - 01/2016
2	PotassiumIBA 12/2019 - 01/2019
2	SodiumIBA 12/2019 - 01/2019

Therapy/Procedure

9	Therapeutics 05/2022 - 11/2006